Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The Federal Trade Commission, concluding that consumers do not read the lengthy lists of side effects required on prescription-drug print ads, is recommending that the Food and Drug Administration provide a simpler way to communicate that information to the public. The FTC suggested that people be directed to more consumer-friendly sources. Current FDA rules require a list of side effects in print and an announcer discussing potential side effects in broadcast direct-to-consumer drug ads.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in